CH505M5 Pr-NP1

CH505M5 Pr-NP1 · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CH505M5 Pr-NP1, covering 2025-03-26 to 2025-03-26. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + Alum [Phase 1]

See pricing